Immunotherapies harness the natural power of our immune system to target and fight disease. Advancements in science and technology have brought about a new wave of promising cancer immunotherapies. This burgeoning field of immuno-oncology (IO) is revolutionizing how we perceive and treat cancer.
In less than 10 years, immunotherapy is projected to form the backbone of over 60% of global cancer management regimes. By conservative estimates, this translates to a projected market value of over $35 billion by 2023.